As CRISPR technology continues to progress, some researchers are turning their focus to discovering or developing countermeasures and controls.
Researchers used the platform to identify small synthetic molecules that disrupt the editing activity of the SpCas9 nuclease.
CRISPR technology has made its way around the world, but in the wake of the He Jiankui controversy, the industry is asking what recourse it has against misuse.
NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.
In PNAS this week: whole-genome assembly for the white shark, paper-based microfluidic method for detecting the malaria parasite, and more.
New Scientist reports on new study of gene drives in mice that found that they might not work as hoped.
In Nature this week: study of gene drive feasibility in lab mice, circulating tumor DNA from cerebrospinal fluid to track glioma progression, and more.
Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.
The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.
In Nature this week: common genetic variants influence monogenic neurodevelopmental disorders, analysis of fruitENCODE, and more.
The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.
US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.
Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.
In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.